Responses
Immune cell therapies and immune cell engineering
Original research
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
Compose a Response to This Article
Other responses
No responses have been published for this article.
